Chemical and biological factors in the control of Brucella and brucellosis

Current Drug Delivery

Volumn 3, Issue 4, 2006, Pages 359-365

  Gamazo, Carlos ^a   Lecároz, María Concepción ^a   Prior, Sandra ^a   Vitas, Ana Isabel ^a   Campanero, Miguel Angel ^b   Irache, Juan Manuel ^a   Blanco Prieto, María José ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Brucella; Brucellosis; Chemotherapy; Drug delivery systems; Gentamicin

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BIOLOGICAL FACTOR; CEPHALOSPORANIC ACID DERIVATIVE; CHLORAMPHENICOL; COMPLEMENT; COTRIMOXAZOLE; DOXYCYCLINE; FC RECEPTOR; FIBRONECTIN RECEPTOR; GENTAMICIN; LECTIN; LIPOSOME; MICROSPHERE; QUINOLONE; RIFAMPICIN; STREPTOMYCIN; TETRACYANOETHYLENE;

ADD ON THERAPY; BRUCELLA MELITENSIS; BRUCELLOSIS; CELL MEMBRANE; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-BACTERIAL AGENTS; BRUCELLA; BRUCELLOSIS; DRUG DELIVERY SYSTEMS; HUMANS; MACROPHAGES; MONOCYTES;

EID: 33749541980     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720106778559038     Document Type: Review

References (61)

1. Allen, L. Microbes. Infect., 2003, 5, 1329-35.
2. Moreno, E., Moriyon, I. Proc. Natl. Acad. Sci. USA, 2002, 99, 1-3.
3. Young, E. J. Clin. Infect. Dis., 1995, 21, 283-9; quiz 290.
4. Ariza, J. Med. Clin. (Barc.), 1983, 81, 870-6.
5. Ariza, J., Gudiol, F., Pallares, R., Rufi, G., Fernandez-Viladrich, P. J. Infect. Dis., 1985, 152, 1358-9.
6. Ariza, J., Gudiol, F., Pallares, R., Rufi, G., Fernandez-Viladrich, P. Antimicrob. Agents Chemother, 1985, 28, 548-51.
7. Ariza, J., Gudiol, F., Pallares, R., Viladrich, P. F., Rufi, G., Corredoira, J., Miravitlles, M. R. Ann. Intern. Med., 1992, 117, 25-30.
8. Domingo, S., Gamazo, C. J. Chemother., 1996, 8, 55-8.
9. Qadri, S., Ueno, Y, Ayub, A. Chemotherapy, 1993, 39, 386-9.
10. Solera, J., Rodriguez-Zapata, M., Geijo, P., Largo, J., Paulino, J., Saez, L., Martinez-Alfaro, E., Sanchez, L., Sepulveda, M. A., Ruiz-Ribo, M. D. Antimicrob. Agents Chemother., 1995, 39, 2061-7.
11. Solera, J., Beato, J. L., Martinez-Alfaro, E., Segura, J. C., de Tomas, E. Clin. Infect. Dis., 2001, 32, 506-9.
12. Garcia-Rodriguez, J. A., Garcia Sanchez, J. E., Trujillano, I. Antimicrob. Agents Chemother., 1991, 35, 756-9.
13. Solera, J., Martinez-Alfaro, E., Espinosa, A. Drugs, 1997, 53, 245-56.
14. Young, E. J. In Brucellosis: Clinical and Laboratory Aspects, E. J. Young, Corbel, M.J., ed., CRC Press: Boca Raton, 1989, pp. 127-41.
15. Zembower, T. R., Noskin, G. A., Postelnick, M. J., Nguyen, C., Peterson, L. R. Int. J. Antimicrob. Agents, 1998, 10, 95-105.
16. Mortensen, J. E., Moore, D. G., Clarridge, J. E., Young, E. J. Diagn. Microbiol. Infect. Dis., 1986, 5, 163-9.
17. Rolain, J. M., Maurin, M., Raoult, D. J. Antimicrob. Chemother., 2000, 46, 811-4.
18. Nix, D., Goodwin, S.D., Peloquin, C.A., Rotella, D.L., Schentag, J.J. Antimicrob. Agents Chemother., 1991, 35, 1953-9.
19. Taber, H. W., Mueller, J. P., Miller, P. F., Arrow, A. S. Microbiol. Rev., 1987, 51, 439-57.
20. Tulkens, P. Scand. J. Infect. Dis. Suppl., 1990, 74, 209-17.
21. Dutt, M., Khuller, G. K. J. Antimicrob. Chemother., 2001, 47, 829-35.
22. Quenelle, D. C., Staas, J. K., Winchester, G. A., Barrow, E. L., Barrow, W. W. Antimicrob. Agents Chemother., 1999, 43, 1144-51.
23. Schiffelers, R., Storm, G., Bakker-Woudenberg, I. J. Antimicrob. Chemother., 2001, 48, 333-44.
24. Swenson, C. E., Stewart, K. A., Hammett, J. L., Fitzsimmons, W. E., Ginsberg, R. S. Antimicrob. Agents Chemother., 1990, 34, 235-40.
25. DelVecchio, V. G., Kapatral, V., Redkar, R. J., Patra, G., Mujer, C., Los, T., Ivanova, N., Anderson, I., Bhattacharyya, A., Lykidis, A., Reznik, G., Jablonski, L., Larsen, N., D'Souza, M., Bernal, A., Mazur, M., Goltsman, E., Selkov, E., Elzer, P. H., Hagius, S., O'Callaghan, D., Letesson, J. J., Haselkorn, R., Kyrpides, N., Overbeek, R. Proc. Natl. Acad. Sci. USA, 2002, 99, 443-8.
26. Hengge-Aronis, R. In Escherichia coli and Salmonella: Cellular and Molecular Biology, Curtiss, R., Neidhardt, F.C., Ingraham III, J.L. Lin, E.C.C., Low, K.B., Magasanik, B., Riley, W.S.M., Reznikoff, M. Schaechter and Umbarger, H.E., eds., American Society for Microbiology Press: Washington D.C. 1996, pp. 1497-1572.
27. Roop, R. M., 2nd, Bellaire, B. H., Valderas, M. W., Cardelli, J. A. Mol. Microbiol., 2004, 52, 621-30.
28. Celli, J., de Chastellier, C., Franchini, D. M., Pizarro-Cerda, J., Moreno, E., Gorvel, J. P. J. Exp. Med., 2003, 198, 545-56.
29. Detilleux, P. G., Deyoe, B. L., Cheville, N. F. Infect. Immun., 1990, 58, 2320-8.
30. Moreno, E., Gorvel, J.P. In Brucella: Molecular and Cellular Biology, I López-Goñi, Moriyón, I., ed., Horizon Bioscience: Norfolk, 2004, pp. 287-312.
31. Pizarro-Cerda, J., Meresse, S., Parton, R. G., van der Goot, G., Sola-Landa, A., Lopez-Goni, I., Moreno, E., Gorvel, J. P. Infect. Immun, 1998, 66, 5711-24.
32. Pizarro-Cerda, J., Moreno, E., Sanguedolce, V., Mege, J. L., Gorvel, J. P. Infect. Immun, 1998, 66, 2387-92.
33. Liautard, J. P., Gross, A., Dornand, J., Kohler, S. Microbiologia, 1996, 12, 197-206.
34. Hancock, R. E., Farmer, S. W., Li, Z. S., Poole, K. Antimicrob. Agents. Chemother, 1991, 35, 1309-14.
35. Kadurugamuwa, J., Clarke, A.J., Beveridge, T.J. J. Bacteriol., 1993, 175, 5798-805.
36. van Bambeke, F., Mingeot-Leclercq, M. P., Brasseur, R., Tulkens, P. M., Schanck, A. Chem. Phys. Lipids, 1996, 79, 123-35.
37. Flórez, J., Armijo, J., Mediavilla, M. In Farmacología. Humana, J. Flórez, ed., Masson: Barcelona, 1997, pp. 1107-16.
38. Pulido, A., Linares, J., Escribano, E., Alonso, T., Ariza, J. Enferm. Infecc. Microbiol. Clin, 1992, 10, 56-7.
39. Qadri, S. M., Ueno, Y., Ayub, A. Chemotherapy, 1993, 39, 386-9.
40. Grabe, M., Oster, G. J. Gen. Physiol, 2001, 117, 329-44.
41. Sandoval, R. M., Dunn, K. W., Molitoris, B. A. Am. J. Physiol. Renal. Physiol., 2000, 279, F884-90.
42. Sandoval, R. M., Molitoris, B. A. Am.. J.. Physiol.. Renal. Physiol., 2004, 286, F617-24.
43. Kalatzis, V., Nevo, N., Cherqui, S., Gasnier, B., Antignac, C. Hum. Mol. Genet., 2004, 13, 1361-71.
44. Wreden, C. C., Johnson, J., Tran, C., Seal, R. P., Copenhagen, D. R., Reimer, R. J., Edwards, R. H. J. Neurosci., 2003, 23, 1265-75.
45. Sandoval, R., Leiser, J., Molitoris, B. A. J. Am. Soc. Nephrol., 1998, 9, 167-74.
46. Sandoval, R. M., Molitoris, B. A. Am. J. Physiol. Renal. Physiol., 2004, 286, F617-24.
47. th Edition , V. Lorian, ed., Williams & Wilkins: Baltimore, USA, 1996, pp. 52-111.
48. Domingo, S., Gastearena, I., Diaz, R., Gamazo, C. J. Chemother., 1995, 7 (Suppl. 4), 29-31.
49. Carryn, S., Chanteux, H., Seral, C., Mingeot-Leclercq, M. P., Van Bambeke, F., Tulkens, P. M. Infect. Dis. Clin. North Am., 2003, 17, 615-34.
50. Maurin, M., Raoult, D. Antimicrob. Agents Chemother., 2001, 45, 2977-86.
51. Grant, T., Bennett-Wood, V., Robins-Browne, R. M. Infect. Immun., 1999, 67, 4367-75.
52. Tabrizi, S. N., Robins-Browne, R. M. J. Immunol. Methods, 1993, 158, 201-6.
53. Drevets, D. A., Canono, B. P., Leenen, P. J., Campbell, P. A. Infect. Immun., 1994, 62, 2222-8.
54. Gonzalez, L. S., Spencer, J. P. Am. Fam. Physician, 1998, 58, 1811-20.
55. Vitas, A. I., Diaz, R., Gamazo, C. Chemotherapy, 1997, 43, 204-10.
56. Vitas, A. I., Diaz, R., Gamazo, C. Antimicrob. Agents Chemother. , 1996, 40, 146-51.
57. Prior, S., Gander, B., Lecaroz, C., Irache, J. M., Gamazo, C. J. Antimicrob. Chemother., 2004, 53, 981-8.
58. Prior, S., Gander, B., Irache, J. M., Gamazo, C. J. Antimicrob. Chemother., 2005, 55, 1032-6.
59. Blanco-Prieto, M., Lecaroz, M.C., Renedo, M.J., Kunkova, J., Gamazo, C. Int. J. Phar., 2002, 242, 203-206.
60. Ahsan, F., Rivas, I. P., Khan, M. A., Torres Suarez, A. I. J. Control. Rel., 2002, 79, 29-40.
61. Newman, K. D., Kwon, G. S., Miller, G. G., Chlumecky, V., Samuel, J. J. Biomed. Mater. Res., 2000, 50, 591-7.